Austin Health

Title
Goal directed fluid therapy for major liver resection: A multicentre randomized controlled trial.
Publication Date
2019-09
Author(s)
Weinberg, Laurence
Ianno, Damian
Churilov, Leonid
Mcguigan, Steven
Mackley, Lois
Banting, Jonathan
Shen, Shi Hong
Riedel, Bernhard
Nikfarjam, Mehrdad
Christophi, Christopher
Subject
Cardiac output
Complications
Fluid therapy
Hemodynamics
Hepatectomy
Monitoring
Surgery
Type of document
Journal Article
OrcId
0000-0001-7403-7680
0000-0002-9807-6606
0000-0003-4866-276X
DOI
10.1016/j.amsu.2019.07.003
Abstract
The effect a restrictive goal directed therapy (GDT) fluid protocol combined with an enhanced recovery after surgery (ERAS) programme on hospital stay for patients undergoing major liver resection is unknown. We conducted a multicentre randomized controlled pilot trial evaluating whether a patient-specific, surgery-specific intraoperative restrictive fluid optimization algorithm would improve duration of hospital stay and reduce perioperative fluid related complications. Forty-eight participants were enrolled. The median (IQR) length of hospital stay was 7.0 days (7.0:8.0) days in the restrictive fluid optimization algorithm group (Restrict group) vs. 8.0 days (6.0:10.0) in the conventional care group (Conventional group) (Incidence rate ratio 0.85; 95% Confidence Interval 0.71:1.1; p = 0.17). No statistically significant difference in expected number of complications per patient between groups was identified (IRR 0.85; 95%CI: 0.45-1.60; p = 0.60). Patients in the Restrict group had lower intraoperative fluid balances: 808 mL (571:1565) vs. 1345 mL (900:1983) (p = 0.04) and received a lower volume of fluid per kg/hour intraoperatively: 4.3 mL/kg/hr (2.6:5.8) vs. 6.0 mL/kg/hr (4.2:7.6); p = 0.03. No significant differences in the proportion of patients who received vasoactive drugs intraoperatively (p = 0.56) was observed. In high-volume hepatobiliary surgical units, the addition of a fluid restrictive intraoperative cardiac output-guided algorithm, combined with a standard ERAS protocol did not significantly reduce length of hospital stay or fluid related complications. Our findings are hypothesis-generating and a larger confirmatory study may be justified.
Link
Citation
Annals of medicine and surgery 2019; 45: 45-53
Jornal Title
Annals of medicine and surgery
ISSN
2049-0801

Files:

NameSizeformatDescriptionLink